LifeVantage Celebrates New TrueScience(TM) Skin Care Regimen Product Launch and Sales Leader Achievements
"Our 2014
This very successful event included:
- Enhanced distributor training and targeted educational subject matter to strengthen our distributor culture;
- Emphasized our expanding sales and marketing programs to support our global network of distributors;
- Launched our new TrueScienceTM Skin Care Regimen in all our existing global markets; and
- Provided the platform for our new Chief Sales Officer and Chief Science Officer to address and motivate many of our global distributors.
"We believe that continuing to focus on our strategic initiatives and delivering tactical results, as seen at our convention, will improve long-term shareholder value," continued Robinson.
About
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our efforts to build long-term shareholder value. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the
CONTACT: Investor Relations Contact:Source:Cindy England (801) 432-9036 Director of Investor Relations -or-John Mills (310) 954-1105 Partner, ICR, INC
News Provided by Acquire Media